Sridhar Kosaraju
Director/Board Member chez 10X GENOMICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Actuellement, Sridhar Kosaraju est directeur général et administrateur d'Inscripta, Inc. Il est également membre du conseil d'administration de 10X Genomics, Inc. Dans le passé, M. Kosaraju a occupé le poste de président de Penumbra, Inc. et de directeur général des marchés des capitaux propres chez JPMorgan Securities LLC. Sridhar Kosaraju a obtenu un diplôme de premier cycle au Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
10X GENOMICS INC CLASS A
0,03% | 14/06/2023 | 35 443 ( 0,03% ) | 1 M $ | 31/03/2024 |
NEVRO CORP.
0,05% | 31/03/2024 | 18 486 ( 0,05% ) | 266 938 $ | 31/03/2024 |
Postes actifs de Sridhar Kosaraju
| Sociétés | Poste | Début |
|---|---|---|
| 10X GENOMICS, INC. | Director/Board Member | 01/03/2019 |
| NEVRO CORP. | Director/Board Member | 31/08/2021 |
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Chief Executive Officer | 27/10/2020 |
| Testing For America | Director/Board Member | - |
Anciens postes connus de Sridhar Kosaraju
| Sociétés | Poste | Fin |
|---|---|---|
| PENUMBRA, INC. | Director of Finance/CFO | 01/11/2019 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01/05/2015 |
Formation de Sridhar Kosaraju
| Massachusetts Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PENUMBRA, INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| NEVRO CORP. | Health Technology |
| Entreprise privées | 3 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
| Testing For America |
